PBMs, the Brokers Who Control Drug Prices, Finally Get Washington’s Attention

For two decades, patients and physicians eagerly awaited a lower-cost version of the world’s bestselling drug, Humira, while its maker, AbbVie, fought off potential competitors by building a wall of more than 250 patents around it. This story also ran on USA Today. It can be republished for free. When […] https://healthmedicinet.com/i/pbms-the-brokers-who-control-drug-prices-finally-get-washingtons-attention/